The Market Reports

Index

1 Antacids Market Overview
1.1 Product Overview and Scope of Antacids
1.2 Antacids Segment by Type
1.2.1 Global Antacids Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Non-Systemic Antacids
1.2.3 Systemic Antacids
1.3 Antacids Segment by Application
1.3.1 Global Antacids Sales Comparison by Application: (2021-2027)
1.3.2 Rx Drug
1.3.3 OTC Drug
1.4 Global Antacids Market Size Estimates and Forecasts
1.4.1 Global Antacids Revenue 2016-2027
1.4.2 Global Antacids Sales 2016-2027
1.4.3 Antacids Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antacids Market Competition by Manufacturers
2.1 Global Antacids Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antacids Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antacids Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antacids Manufacturing Sites, Area Served, Product Type
2.5 Antacids Market Competitive Situation and Trends
2.5.1 Antacids Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antacids Players Market Share by Revenue
2.5.3 Global Antacids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antacids Retrospective Market Scenario by Region
3.1 Global Antacids Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antacids Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antacids Market Facts & Figures by Country
3.3.1 North America Antacids Sales by Country
3.3.2 North America Antacids Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antacids Market Facts & Figures by Country
3.4.1 Europe Antacids Sales by Country
3.4.2 Europe Antacids Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antacids Market Facts & Figures by Region
3.5.1 Asia Pacific Antacids Sales by Region
3.5.2 Asia Pacific Antacids Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antacids Market Facts & Figures by Country
3.6.1 Latin America Antacids Sales by Country
3.6.2 Latin America Antacids Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antacids Market Facts & Figures by Country
3.7.1 Middle East and Africa Antacids Sales by Country
3.7.2 Middle East and Africa Antacids Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antacids Historic Market Analysis by Type
4.1 Global Antacids Sales Market Share by Type (2016-2021)
4.2 Global Antacids Revenue Market Share by Type (2016-2021)
4.3 Global Antacids Price by Type (2016-2021)

5 Global Antacids Historic Market Analysis by Application
5.1 Global Antacids Sales Market Share by Application (2016-2021)
5.2 Global Antacids Revenue Market Share by Application (2016-2021)
5.3 Global Antacids Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Antacids Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Antacids Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Takeda Pharmaceutical
6.2.1 Takeda Pharmaceutical Corporation Information
6.2.2 Takeda Pharmaceutical Description and Business Overview
6.2.3 Takeda Pharmaceutical Antacids Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Takeda Pharmaceutical Antacids Product Portfolio
6.2.5 Takeda Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antacids Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Antacids Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Reckitt Benckiser
6.4.1 Reckitt Benckiser Corporation Information
6.4.2 Reckitt Benckiser Description and Business Overview
6.4.3 Reckitt Benckiser Antacids Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Reckitt Benckiser Antacids Product Portfolio
6.4.5 Reckitt Benckiser Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Antacids Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer Antacids Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Procter & Gamble
6.6.1 Procter & Gamble Corporation Information
6.6.2 Procter & Gamble Description and Business Overview
6.6.3 Procter & Gamble Antacids Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Procter & Gamble Antacids Product Portfolio
6.6.5 Procter & Gamble Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Antacids Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Antacids Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Antacids Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Johnson & Johnson Antacids Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 CONBA
6.9.1 CONBA Corporation Information
6.9.2 CONBA Description and Business Overview
6.9.3 CONBA Antacids Sales, Revenue and Gross Margin (2016-2021)
6.9.4 CONBA Antacids Product Portfolio
6.9.5 CONBA Recent Developments/Updates
6.10 Xiuzheng Pharma
6.10.1 Xiuzheng Pharma Corporation Information
6.10.2 Xiuzheng Pharma Description and Business Overview
6.10.3 Xiuzheng Pharma Antacids Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Xiuzheng Pharma Antacids Product Portfolio
6.10.5 Xiuzheng Pharma Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Antacids Description and Business Overview
6.11.3 Sanofi Antacids Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sanofi Antacids Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Bausch Health
6.12.1 Bausch Health Corporation Information
6.12.2 Bausch Health Antacids Description and Business Overview
6.12.3 Bausch Health Antacids Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Bausch Health Antacids Product Portfolio
6.12.5 Bausch Health Recent Developments/Updates
6.13 CR SANJIU
6.13.1 CR SANJIU Corporation Information
6.13.2 CR SANJIU Antacids Description and Business Overview
6.13.3 CR SANJIU Antacids Sales, Revenue and Gross Margin (2016-2021)
6.13.4 CR SANJIU Antacids Product Portfolio
6.13.5 CR SANJIU Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Antacids Description and Business Overview
6.14.3 Novartis Antacids Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novartis Antacids Product Portfolio
6.14.5 Novartis Recent Developments/Updates

7 Antacids Manufacturing Cost Analysis
7.1 Antacids Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antacids
7.4 Antacids Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antacids Distributors List
8.3 Antacids Customers

9 Antacids Market Dynamics
9.1 Antacids Industry Trends
9.2 Antacids Growth Drivers
9.3 Antacids Market Challenges
9.4 Antacids Market Restraints

10 Global Market Forecast
10.1 Antacids Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antacids by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antacids by Type (2022-2027)
10.2 Antacids Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antacids by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antacids by Application (2022-2027)
10.3 Antacids Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antacids by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antacids by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Antacids Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antacids Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Antacids Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antacids Covered in This Study
Table 5. Global Antacids Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Antacids Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antacids Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antacids Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antacids Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antacids Manufacturing Sites and Area Served
Table 11. Manufacturers Antacids Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antacids by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antacids as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antacids Sales by Region (2016-2021) & (K Units)
Table 16. Global Antacids Sales Market Share by Region (2016-2021)
Table 17. Global Antacids Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antacids Sales by Country (2016-2021) & (K Units)
Table 19. North America Antacids Sales Market Share by Country (2016-2021)
Table 20. North America Antacids Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antacids Revenue Market Share by Country (2016-2021)
Table 22. Europe Antacids Sales by Country (2016-2021) & (K Units)
Table 23. Europe Antacids Sales Market Share by Country (2016-2021)
Table 24. Europe Antacids Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antacids Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antacids Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Antacids Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antacids Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antacids Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antacids Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Antacids Sales Market Share by Country (2016-2021)
Table 32. Latin America Antacids Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antacids Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antacids Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Antacids Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antacids Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antacids Revenue Market Share by Country (2016-2021)
Table 38. Global Antacids Sales (K Units) by Type (2016-2021)
Table 39. Global Antacids Sales Market Share by Type (2016-2021)
Table 40. Global Antacids Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antacids Revenue Share by Type (2016-2021)
Table 42. Global Antacids Price (US$/Unit) by Type (2016-2021)
Table 43. Global Antacids Sales (K Units) by Application (2016-2021)
Table 44. Global Antacids Sales Market Share by Application (2016-2021)
Table 45. Global Antacids Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antacids Revenue Share by Application (2016-2021)
Table 47. Global Antacids Price (US$/Unit) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. AstraZeneca Antacids Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Takeda Pharmaceutical Corporation Information
Table 54. Takeda Pharmaceutical Description and Business Overview
Table 55. Takeda Pharmaceutical Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Takeda Pharmaceutical Antacids Product
Table 57. Takeda Pharmaceutical Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Antacids Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Reckitt Benckiser Corporation Information
Table 64. Reckitt Benckiser Description and Business Overview
Table 65. Reckitt Benckiser Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Reckitt Benckiser Antacids Product
Table 67. Reckitt Benckiser Recent Developments/Updates
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Business Overview
Table 70. Bayer Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Bayer Antacids Product
Table 72. Bayer Recent Developments/Updates
Table 73. Procter & Gamble Corporation Information
Table 74. Procter & Gamble Description and Business Overview
Table 75. Procter & Gamble Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Procter & Gamble Antacids Product
Table 77. Procter & Gamble Recent Developments/Updates
Table 78. GlaxoSmithKline Corporation Information
Table 79. GlaxoSmithKline Description and Business Overview
Table 80. GlaxoSmithKline Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. GlaxoSmithKline Antacids Product
Table 82. GlaxoSmithKline Recent Developments/Updates
Table 83. Johnson & Johnson Corporation Information
Table 84. Johnson & Johnson Description and Business Overview
Table 85. Johnson & Johnson Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Johnson & Johnson Antacids Product
Table 87. Johnson & Johnson Recent Developments/Updates
Table 88. CONBA Corporation Information
Table 89. CONBA Description and Business Overview
Table 90. CONBA Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. CONBA Antacids Product
Table 92. CONBA Recent Developments/Updates
Table 93. Xiuzheng Pharma Corporation Information
Table 94. Xiuzheng Pharma Description and Business Overview
Table 95. Xiuzheng Pharma Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Xiuzheng Pharma Antacids Product
Table 97. Xiuzheng Pharma Recent Developments/Updates
Table 98. Sanofi Corporation Information
Table 99. Sanofi Description and Business Overview
Table 100. Sanofi Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Sanofi Antacids Product
Table 102. Sanofi Recent Developments/Updates
Table 103. Bausch Health Corporation Information
Table 104. Bausch Health Description and Business Overview
Table 105. Bausch Health Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Bausch Health Antacids Product
Table 107. Bausch Health Recent Developments/Updates
Table 108. CR SANJIU Corporation Information
Table 109. CR SANJIU Description and Business Overview
Table 110. CR SANJIU Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. CR SANJIU Antacids Product
Table 112. CR SANJIU Recent Developments/Updates
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Business Overview
Table 115. Novartis Antacids Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Novartis Antacids Product
Table 117. Novartis Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Antacids Distributors List
Table 121. Antacids Customers List
Table 122. Antacids Market Trends
Table 123. Antacids Growth Drivers
Table 124. Antacids Market Challenges
Table 125. Antacids Market Restraints
Table 126. Global Antacids Sales Forecast by Type (2022-2027) & (K Units)
Table 127. Global Antacids Sales Market Share Forecast by Type (2022-2027)
Table 128. Global Antacids Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 129. Global Antacids Revenue Market Share Forecast by Type (2022-2027)
Table 130. Global Antacids Sales Forecast by Application (2022-2027) & (K Units)
Table 131. Global Antacids Sales Market Share Forecast by Application (2022-2027)
Table 132. Global Antacids Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 133. Global Antacids Revenue Market Share Forecast by Application (2022-2027)
Table 134. Global Antacids Sales Forecast by Region (2022-2027) & (K Units)
Table 135. Global Antacids Sales Market Share Forecast by Region (2022-2027)
Table 136. Global Antacids Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 137. Global Antacids Revenue Market Share Forecast by Region (2022-2027)
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antacids
Figure 2. Global Antacids Market Share by Type in 2020 & 2027
Figure 3. Non-Systemic Antacids Product Picture
Figure 4. Systemic Antacids Product Picture
Figure 5. Global Antacids Market Share by Application in 2020 & 2027
Figure 6. Rx Drug
Figure 7. OTC Drug
Figure 8. Global Antacids Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Antacids Market Size 2016-2027 (US$ Million)
Figure 10. Global Antacids Sales 2016-2027 (K Units)
Figure 11. Global Antacids Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Antacids Sales Share by Manufacturers in 2020
Figure 13. Global Antacids Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Antacids Players: Market Share by Revenue in 2020
Figure 15. Antacids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Antacids Sales Market Share by Region (2016-2021)
Figure 17. Global Antacids Sales Market Share by Region in 2020
Figure 18. Global Antacids Revenue Market Share by Region (2016-2021)
Figure 19. Global Antacids Revenue Market Share by Region in 2020
Figure 20. U.S. Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Antacids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Antacids by Type (2016-2021)
Figure 45. Sales Market Share of Antacids by Application (2016-2021)
Figure 46. Sales Market Share of Antacids by Application in 2020
Figure 47. Revenue Share of Antacids by Application (2016-2021)
Figure 48. Revenue Share of Antacids by Application in 2020
Figure 49. Manufacturing Cost Structure of Antacids
Figure 50. Manufacturing Process Analysis of Antacids
Figure 51. Antacids Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed